Literature DB >> 24695732

Differential regulation of primary afferent input to spinal cord by muscarinic receptor subtypes delineated using knockout mice.

Shao-Rui Chen1, Hong Chen1, Wei-Xiu Yuan1, Jürgen Wess2, Hui-Lin Pan3.   

Abstract

Stimulation of muscarinic acetylcholine receptors (mAChRs) inhibits nociceptive transmission at the spinal level. However, it is unclear how each mAChR subtype regulates excitatory synaptic input from primary afferents. Here we examined excitatory postsynaptic currents (EPSCs) of dorsal horn neurons evoked by dorsal root stimulation in spinal cord slices from wild-type and mAChR subtype knock-out (KO) mice. In wild-type mice, mAChR activation with oxotremorine-M decreased the amplitude of monosynaptic EPSCs in ∼67% of neurons but increased it in ∼10% of neurons. The inhibitory effect of oxotremorine-M was attenuated by the M2/M4 antagonist himbacine in the majority of neurons, and the remaining inhibition was abolished by group II/III metabotropic glutamate receptor (mGluR) antagonists in wild-type mice. In M2/M4 double-KO mice, oxotremorine-M inhibited monosynaptic EPSCs in significantly fewer neurons (∼26%) and increased EPSCs in significantly more neurons (33%) compared with wild-type mice. Blocking group II/III mGluRs eliminated the inhibitory effect of oxotremorine-M in M2/M4 double-KO mice. In M2 single-KO and M4 single-KO mice, himbacine still significantly reduced the inhibitory effect of oxotremorine-M. However, the inhibitory and potentiating effects of oxotremorine-M on EPSCs in M3 single-KO and M1/M3 double-KO mice were similar to those in wild-type mice. In M5 single-KO mice, oxotremorine-M failed to potentiate evoked EPSCs, and its inhibitory effect was abolished by himbacine. These findings indicate that activation of presynaptic M2 and M4 subtypes reduces glutamate release from primary afferents. Activation of the M5 subtype either directly increases primary afferent input or inhibits it through indirectly stimulating group II/III mGluRs.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Acetylcholine; Acetylcholinesterase; Cholinergic Receptor; Gene Knockout; Glutamate; Muscarinic; Neurons; Pain; Spinal Cord; Synaptic Plasticity

Mesh:

Substances:

Year:  2014        PMID: 24695732      PMCID: PMC4022898          DOI: 10.1074/jbc.M114.550384

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  44 in total

1.  Enhancement of analgesia from systemic opioid in humans by spinal cholinesterase inhibition.

Authors:  D D Hood; K A Mallak; R L James; R Tuttle; J C Eisenach
Journal:  J Pharmacol Exp Ther       Date:  1997-07       Impact factor: 4.030

Review 2.  Molecular biology of muscarinic acetylcholine receptors.

Authors:  J Wess
Journal:  Crit Rev Neurobiol       Date:  1996

Review 3.  Metabotropic glutamate receptors: electrophysiological properties and role in plasticity.

Authors:  R Anwyl
Journal:  Brain Res Brain Res Rev       Date:  1999-01

4.  Immunocytochemical localization of muscarinic m2 receptor in the rat spinal cord.

Authors:  K K Yung; Y L Lo
Journal:  Neurosci Lett       Date:  1997-06-27       Impact factor: 3.046

Review 5.  Pharmacology and functions of metabotropic glutamate receptors.

Authors:  P J Conn; J P Pin
Journal:  Annu Rev Pharmacol Toxicol       Date:  1997       Impact factor: 13.820

6.  M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord.

Authors:  A U Höglund; H A Baghdoyan
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

7.  Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.

Authors:  D Doller; S Chackalamannil; M Czarniecki; R McQuade; V Ruperto
Journal:  Bioorg Med Chem Lett       Date:  1999-03-22       Impact factor: 2.823

8.  Group III metabotropic glutamate receptor agonists modulate high voltage-activated Ca2+ currents in pyramidal neurons of the adult rat.

Authors:  A Stefani; F Spadoni; G Bernardi
Journal:  Exp Brain Res       Date:  1998-03       Impact factor: 1.972

9.  Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice.

Authors:  J Gomeza; H Shannon; E Kostenis; C Felder; L Zhang; J Brodkin; A Grinberg; H Sheng; J Wess
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems.

Authors:  M Naguib; T L Yaksh
Journal:  Anesthesiology       Date:  1994-06       Impact factor: 7.892

View more
  10 in total

1.  Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback.

Authors:  Klaus Deckmann; Amir Rafiq; Christian Erdmann; Christian Illig; Melanie Durschnabel; Jürgen Wess; Wolfgang Weidner; Thomas Bschleipfer; Wolfgang Kummer
Journal:  FASEB J       Date:  2018-01-17       Impact factor: 5.191

Review 2.  Physiological roles of CNS muscarinic receptors gained from knockout mice.

Authors:  Morgane Thomsen; Gunnar Sørensen; Ditte Dencker
Journal:  Neuropharmacology       Date:  2017-09-11       Impact factor: 5.250

Review 3.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

4.  RE1-silencing transcription factor controls the acute-to-chronic neuropathic pain transition and Chrm2 receptor gene expression in primary sensory neurons.

Authors:  Jixiang Zhang; Shao-Rui Chen; Hong Chen; Hui-Lin Pan
Journal:  J Biol Chem       Date:  2018-10-16       Impact factor: 5.157

5.  Regulating nociceptive transmission by VGluT2-expressing spinal dorsal horn neurons.

Authors:  Li Wang; Shao-Rui Chen; Huijie Ma; Hong Chen; Walter N Hittelman; Hui-Lin Pan
Journal:  J Neurochem       Date:  2018-10-31       Impact factor: 5.372

6.  Muscarinic receptor subtypes differentially control synaptic input and excitability of cerebellum-projecting medial vestibular nucleus neurons.

Authors:  Yun Zhu; Shao-Rui Chen; Hui-Lin Pan
Journal:  J Neurochem       Date:  2016-02-15       Impact factor: 5.372

7.  Cholinergic mechanisms in spinal locomotion-potential target for rehabilitation approaches.

Authors:  Larry M Jordan; J R McVagh; B R Noga; A M Cabaj; H Majczyński; Urszula Sławińska; J Provencher; H Leblond; Serge Rossignol
Journal:  Front Neural Circuits       Date:  2014-11-06       Impact factor: 3.492

8.  Cholinergic Nociceptive Mechanisms in Rat Meninges and Trigeminal Ganglia: Potential Implications for Migraine Pain.

Authors:  Irina Shelukhina; Nikita Mikhailov; Polina Abushik; Leniz Nurullin; Evgeny E Nikolsky; Rashid Giniatullin
Journal:  Front Neurol       Date:  2017-04-27       Impact factor: 4.003

Review 9.  Acetylcholine and spinal locomotor networks: The insider.

Authors:  Théo Mille; Camille Quilgars; Jean-René Cazalets; Sandrine S Bertrand
Journal:  Physiol Rep       Date:  2021-02

Review 10.  Molecular, Cellular and Circuit Basis of Cholinergic Modulation of Pain.

Authors:  Paul V Naser; Rohini Kuner
Journal:  Neuroscience       Date:  2017-09-08       Impact factor: 3.590

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.